(LML) Single-dose rifampicin chemoprophylaxis

Leprosy Mailing List – June 10,  2018

Ref.:  (LML) Single-dose rifampicin chemoprophylaxis 

From:  Ben Naafs, Munnekeburen, the Netherlands

---

 

Dear Pieter

 

 

Some time ago, Dr. Diana Lockwood ask for comments concerning Single-dose rifampicin (SDR) chemoprphylaxis in a letter to LML.

 

Recently, the following article was published: Lockwood DNJ, Krishnamurthy P, Kumar B, Penna G (2018) Single-dose rifampicin chemoprophylaxis protects those who need it least and is not a cost-effective intervention. PLoS Negl Trop Dis 12(6): e0006403. https://doi.org/10.1371/journal.pntd.0006403

 

http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006403

 

 

We strongly recommend reading this publication. It is important that we as leprologists keep reviewing leprosy control policies critically. 

 

 

 

Regards,

 

 

Ben

---

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com